In KEGG pathways, the hub genes were mainly enriched in the IL-17 signaling pathway, transcriptional misregulation in cancer, microRNAs in cancer, base excision repair, bladder cancer, drug metabolism-other enzymes, acute myeloid leukemia, ECM-receptor interaction, endocrine resistance, and progesterone-mediated oocyte maturation (Figure 7(b)). The gene discussed is IL17A; the disease is acute myeloid leukemia.